Brivaracetam Oral Solution
Product Images NDC 67877-904

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Brivaracetam Oral Solution (NDC 67877-904). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Briva-10mg-per-ml-cart-label-a (Briva 10mg Per mL Cart Label A)

Packaging label for Brivaracetam Oral Solution 10 mg/mL, a 300 mL oral solution product. The label includes dosing storage instructions, pharmacist dispensing guidance, and manufacturer and distributor information. Manufactured by Alkem Laboratories Ltd., India, and distributed by Ascend Laboratories, LLC, Bedminster, NJ.*

FDA Label Image

Briva-10mg-per-ml-cont-label-a1 (Briva 10mg Per mL Cont Label A1)

Label for Brivaracetam Oral Solution 10 mg/mL, a human prescription drug oral solution. The label specifies each mL contains 10 mg of brivaracetam, with a 300 mL bottle size. It includes storage instructions, pharmacist dispensing guidance, Rx only designation, and the labeler Ascend Laboratories, LLC. The label also shows the NDC 67877-904-58 and manufacturer Alkem Laboratories, Ltd., Mumbai, India.*

FDA Label Image

Briva-fig-1 (Briva Fig 1)

Bar chart showing the proportion of patients (%) experiencing various levels of reduction in seizure frequency from baseline for placebo and Brivaracetam Oral Solution at 50 mg/day, 100 mg/day, and 200 mg/day dosages. The X-axis categorizes reduction percentages from 'Worse' to '75 to 100', while the Y-axis indicates the proportion of patients. Bars represent data for placebo and each dosage group, illustrating comparative patient responses.*

FDA Label Image

Briva-str (Briva Str)

Chemical structure diagram of Brivaracetam, showing its molecular framework with chemical bonds and functional groups clearly illustrated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.